Sundaram Finance Board Recommends Final Dividend of ₹24 Per Share
Sundaram Finance has announced a final dividend of ₹24 per share for the financial year ended March 31, 2026. When combined with the interim…
KEC International Record Financial Performance and Strategic Growth in FY26
KEC International has achieved a record-breaking performance in FY26, posting revenues of ₹23,506 crore, an 8% year-over-year increase. The…
Sundaram Finance Reports Strong Financial Growth and Declares Final Dividend for FY26
Sundaram Finance has delivered a robust performance for the financial year ended March 31, 2026. The company reported a standalone Profit…
Zensar Technologies Delivering Growth and AI-Native Transformation in FY26
Zensar Technologies has reported a strong fiscal year 2026, achieving a total revenue of $643.7 million, representing a 3.1% year-on-year…
Tata Chemicals C. R. Sriniwas Appointed as New Chief Human Resources Officer
Tata Chemicals Limited has announced the appointment of Mr. C. R. Sriniwas as the new Chief Human Resources Officer (CHRO), effective June 1,…
Entero Healthcare Solutions Limited Board Approves Financial Results and Strategic Acquisitions
Entero Healthcare Solutions Limited announced its audited financial results for the quarter and year ended March 31, 2026. The Board approved…
Entero Healthcare Solutions Q4 FY2026 Financial Results and Strategic Acquisitions
Entero Healthcare Solutions announced robust results for Q4 FY2026, reporting a consolidated net profit of Rs. 451.28 million and revenue of…
Entero Healthcare Solutions Strong Financial Performance and Strategic Expansion Announced
Entero Healthcare Solutions Limited has reported robust financial results for the fiscal year ended March 31, 2026. The company achieved a…
Entero Healthcare Solutions Q4 Financial Performance and Strategic Expansion Announcement
Entero Healthcare Solutions Limited reported a solid performance for the quarter and year ended March 31, 2026. The company announced audited…
Aarti Pharmalabs Audited Financial Results and Final Dividend Announcement
Aarti Pharmalabs has reported its financial performance for the quarter and year ended March 31, 2026. The board has recommended a final…